MDMA for the treatment of mood disorder: all talk no substance? - Wikidata - awgldk - TriplyDB

MDMA for the treatment of mood disorder: all talk no substance?

MDMA for the treatment of mood disorder: all talk no substance?

http://www.wikidata.org/entity/Q21558551

about

(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.

P2860

Q47777762-6994F596-D6EA-4DFB-AEF4-1F932AAB4FA0

P2860

MDMA for the treatment of mood disorder: all talk no substance?

http://www.wikidata.org/entity/Q21558551

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

MDMA for the treatment of mood disorder: all talk no substance?

@ast

MDMA for the treatment of mood disorder: all talk no substance?

@en

MDMA for the treatment of mood disorder: all talk no substance?

@en-gb

MDMA for the treatment of mood disorder: all talk no substance?

@nl

type

label

MDMA for the treatment of mood disorder: all talk no substance?

@ast

MDMA for the treatment of mood disorder: all talk no substance?

@en

MDMA for the treatment of mood disorder: all talk no substance?

@en-gb

MDMA for the treatment of mood disorder: all talk no substance?

@nl

prefLabel

MDMA for the treatment of mood disorder: all talk no substance?

@ast

MDMA for the treatment of mood disorder: all talk no substance?

@en

MDMA for the treatment of mood disorder: all talk no substance?

@en-gb

MDMA for the treatment of mood disorder: all talk no substance?

@nl

P1433

Q21558551-C07DE13A-3122-4254-842B-63781418AB0D

P1476

Q21558551-0EBB23F9-DD0C-48D8-BCC6-284492881D5F

P2093

Q21558551-2BDD76E0-6E10-447C-9BBD-3DB0A405EBBA

Q21558551-3C94B47A-5829-4E7D-B915-985C928165C9

P2860

Q21558551-08CEFC1D-3DBD-46C0-94AC-2F0EDB4EB740

Q21558551-08D39B35-EFBD-4341-AE5B-E013AD69C11A

Q21558551-096D8CBB-0256-4025-BAC3-DE19597625AE

Q21558551-0BB834C8-9606-4347-B60B-0B96A6C7BA00

Q21558551-1017D91A-7A72-4F90-82EC-6BD3D223F1E7

Q21558551-171E329A-1904-4EEB-928B-6C57EEB9A987

Q21558551-1C84D860-0C51-42D6-AFF6-0FA67A8352FC

Q21558551-25BD80F9-F26D-4C05-8313-3D556C8F0F30

Q21558551-2655E362-DED1-4BCC-9B38-257626424C9A

Q21558551-28980ECE-8615-4A9B-AA39-672FAA4AF080

P304

Q21558551-17F29DD2-0F67-46F4-9419-0B9F0B1A52B9

P31

Q21558551-04DB7279-4FF5-4671-82D9-83BB9261F33A

P356

Q21558551-E70D62F8-AFFB-4BCA-8A68-A9E7BC93E402

P407

Q21558551-E10D4DBE-5B6C-4E7E-94AB-AE18680607A7

P433

Q21558551-047FED0B-BA62-46E6-AE55-E351C26EA9FA

P478

Q21558551-E2EB7EBB-A61B-494E-BDF8-2002EF4DB7C2

P577

Q21558551-CA8E72E4-D28D-4F7E-AC7B-C2339A0D4EF4

P698

Q21558551-2AB038B8-2DAC-47D7-BB0B-2AA66394899B

P932

Q21558551-62B78D31-E31B-432C-92EC-873428B0C15B

P356

2045125315583786

P1433

Therapeutic advances in psychopharmacology

P1476

MDMA for the treatment of mood disorder: all talk no substance?

@en

P2093

Daniel Titheradge

http://www.w3.org/2001/XMLSchema#string

Rachel Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity of amphetamines: an update

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

The molecular neurobiology of depression

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice

No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation

Neurobiology of depression

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Effects of MDMA and Intranasal oxytocin on social and emotional processing.

P304

179-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2045125315583786

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26199721

http://www.w3.org/2001/XMLSchema#string

P932

4502590

http://www.w3.org/2001/XMLSchema#string